标题
Vaccine Against PCSK9 Improved Renal Fibrosis by Regulating Fatty Acid β‐Oxidation
作者
关键词
-
出版物
Journal of the American Heart Association
Volume 9, Issue 1, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-12-24
DOI
10.1161/jaha.119.014358
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protein convertase subtilisin/kexin type 9 biology in nephrotic syndrome: implications for use as therapy
- (2019) Ruxandra Mihaela Busuioc et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease
- (2019) Tariq E. Farrah et al. HYPERTENSION
- Impairment of PPARαand the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging
- (2018) Ki Wung Chung et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease
- (2018) Peter P. Toth et al. KIDNEY INTERNATIONAL
- Renal fibrosis: Primacy of the proximal tubule
- (2018) Leslie S. Gewin MATRIX BIOLOGY
- Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps
- (2018) Andrea Baragetti et al. PHARMACOLOGICAL RESEARCH
- PCSK9 in chronic kidney disease
- (2017) P. Pavlakou et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Chronic Kidney Disease
- (2017) Angela C Webster et al. LANCET
- Successful treatment of a patient with refractory nephrotic syndrome with PCSK9 inhibitors: a case report
- (2017) Yuki Awanami et al. BMC Nephrology
- A Therapeutic Peptide Vaccine Against PCSK9
- (2017) Yajie Pan et al. Scientific Reports
- The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated HypercholesterolemiaClinical Perspective
- (2016) Mary E. Haas et al. CIRCULATION
- Vaccine strategies for lowering LDL by immunization against proprotein convertase subtilisin/kexin type 9
- (2016) Bryce Chackerian et al. CURRENT OPINION IN LIPIDOLOGY
- Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
- (2016) Dhruv S. Kazi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection
- (2016) Mei T. Tran et al. NATURE
- PCSK9: a target for hypercholesterolaemia in nephrotic syndrome
- (2016) Alan W. J. Morris Nature Reviews Nephrology
- PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension
- (2015) Jean-Mathieu Berger et al. ATHEROSCLEROSIS
- Up-regulation of liver Pcsk9 gene expression as a possible cause of hypercholesterolemia in experimental chronic renal failure
- (2015) Elzbieta Sucajtys-Szulc et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Lipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis
- (2014) Shenaz Khan et al. JOURNAL OF CLINICAL INVESTIGATION
- Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
- (2014) Hyun Mi Kang et al. NATURE MEDICINE
- PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells
- (2013) Emile Levy et al. ATHEROSCLEROSIS
- Proprotein convertase subtilisin–kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment
- (2012) Arjan J. Kwakernaak et al. ATHEROSCLEROSIS
- An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes
- (2012) Liwen Zhang et al. International Journal of Biological Sciences
- Regulation of Epithelial Sodium Channel Trafficking by Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
- (2012) Vikas Sharotri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peroxisome Proliferator-activated Receptor γ Activation by Ligands and Dephosphorylation Induces Proprotein Convertase Subtilisin Kexin Type 9 and Low Density Lipoprotein Receptor Expression
- (2012) Yajun Duan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
- (2012) B. N. Chau et al. Science Translational Medicine
- Circulating Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Regulates VLDLR Protein and Triglyceride Accumulation in Visceral Adipose Tissue
- (2011) Anna Roubtsova et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Selective Endothelin-A Receptor Antagonism Reduces Proteinuria, Blood Pressure, and Arterial Stiffness in Chronic Proteinuric Kidney Disease
- (2011) Neeraj Dhaun et al. HYPERTENSION
- PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice
- (2011) Mei Tran et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started